Download presentation
Presentation is loading. Please wait.
Published byMelina McKenzie Modified over 9 years ago
1
KADA DA, A KADA NE ERCP Prof.dr.sc.Žarko Babić KB Dubrava, Zagreb Klinika za unutarnje bolesti Zavod za gastroenterologiju Odjel za gastroenterologiju
2
Indications Evaluation of chronic pancreatitis Recurrent cholangitis Evaluation of possible cancer of the biliary tree and/or pancreas Choledocholithiasis (ductal stones) Removal of retained bile or pancreatic stones Pre- or post-operative cholecystectomy when ductal stones are suspected Chronic or acute abdominal pain when bile duct disease is suspected
3
Indications Suspected primary sclerosing cholangitis (PSC) Evaluation of abnormal biliary system findings from a CT, EUS or MRCP Obstructive jaundice Dilated CBD (common bile duct) Tissue sampling
4
Indications Biliary strictures Sphincter of Oddi dysfunction Palliative or pre-operative stenting of malignant biliary or pancreatic strictures Treatment of bile leaks (biliary ducts or pancratic duct) Pancreatic fluid colections (pseudocysts and necrosis-that communicate with pancreatic duct)
5
Indications-conclusion TODAY: Therapeutic ERCP Always is indicated in: -Conditions that need immidiate attention and resolution (diagnostic, therapeutic-papilotomy, dilatation, drainage, stenting, ampulectomy etc.) -Bile duct (pancreatic duct) dilatation with laboratory signs of cholestasis ( bilirubin, GGT, ALP)
6
Contraindications MAJOR: The risk of sedation GENERAL: Recent myocardial infarction Visceral perforation, Risk of perforation – (some duodenal diverticula, anatomyc abnormalities) Recent barium enema-superposition Who cannot cooperate RELATIVE: 1) Patient’s needs vrs. Patient’s current condition (eg.: may be unstabile due to an infection that is resolved with procedure-biliary sepsis) 2) Coagulopathy (correction !)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.